Results 201 to 210 of about 683,224 (393)

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

open access: yesMolecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski   +19 more
wiley   +1 more source

Do Strict Electoral Campaign Finance Rules Limit Corruption? [PDF]

open access: yes
Wahlkampffinanzierung, Parteienfinanzierung, Korruption, Österreich, Frankreich, Deutschland, Japan, , Vereinigte Staaten, Campaign finance, Party finance, Corruption, Austria, France, Germany, United ...
Thomas Stratmann
core  

Erratum zu: Geringeres Risiko für Postinjektionssyndrome nach Vergabe von Olanzapin-Depot. [PDF]

open access: yesNervenarzt
Strube W   +5 more
europepmc   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

open access: yesMolecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau   +9 more
wiley   +1 more source

The Impact of Environmental Regulation on Competitiveness in the European Cement Industry - Results of a Matched Plant Comparison between Germany, Spain and the UK [PDF]

open access: yes
Zementindustrie, Umweltauflage, Internationaler Wettbewerb, Vergleich, EU-Staaten, Großbritannien, Spanien, Deutschland, Cement industry, Environmental regulation, Global competition, Comparison, EU countries, United Kingdom, Spain ...
D. Hitchens, Ursula Triebswetter
core  

[Pharmacy reloaded-Comprehensive competence in all aspects of pharmaceuticals]. [PDF]

open access: yesBundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Jaehde U, Heisig P.
europepmc   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

open access: yesMolecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy